Advertisement

Topics

J&J accepts binding offer from platinum equity to acquire LifeScan

08:16 EDT 14 Jun 2018 | PharmaBiz

Johnson & Johnson has announced that it has accepted the binding offer from Platinum Equity, previously announced on March 16, 2018, to acquire its LifeScan business for approximately USD 2.1 billion.

Original Article: J&J accepts binding offer from platinum equity to acquire LifeScan

NEXT ARTICLE

More From BioPortfolio on "J&J accepts binding offer from platinum equity to acquire LifeScan"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...